ERGOMED Ergomed Plc
('Ergomed' or the 'Company')
Directors' Dealing
Ergomed, a profitable UK-based group dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, announces that on 1 February 2018, Mr Peter George, Chairman of the Company, bought 500,000 ordinary shares of 1p each in the Company ('Share(s)') at a price of 190p per Share from Dr Miroslav Reljanovic, founder and Executive Vice-Chairman of the Company. Separately, in response to excess demand from the placing announced by the Company this morning, Dr Miroslav Reljanovic sold an additional 2,000,000 Shares at a price of 190p.
Following these transactions, Mr Peter George holds 776,250 shares (representing 1.8 per cent. of the Company's issued share capital and 1.7 per cent. of the Company's issued share capital following admission of the Placing Shares relating to the Placing announced by the Company earlier this morning) and Dr Miroslav Reljanovic's holding has reduced to 15,132,237 shares (representing 35.5 per cent. of the Company's issued share capital and 33.8 per cent. of the Company's issued share capital following admission of the Placing Shares relating to the Placing announced by the Company earlier this morning).
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 | Details of the person discharging managerial responsibilities/person closely associated | ||
a) | Name | 1) Peter George 2) Dr Miroslav Reljanovic | |
2 | Reason for the notification | ||
a) | Position/status | 1) Chairman 2) Founder and Executive Vice-Chairman | |
b) | Initial notification /Amendment | Initial Notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Ergomed Plc | |
b) | Legal Entity Identifier | 213800BVS8I9VMC1AP84 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 1 pence each GB00BN7ZCY67 | |
b) | Nature of the transaction | 1) Purchase of shares 2) Sale of shares | |
c) | Currency | GBP | |
d) | Price(s) and volume(s) | Price(s) | Volume(s) |
190p | 500,000 | ||
190p | 2,500,000 | ||
e) | Aggregated information - Aggregated volume - Price - Aggregated total | 1) 500,000 2) 2,500,000 1) 190p 2) 190p 1) £950,000.00 2) £4,750,000.00 | |
f) | Date of the transaction | 1 February 2018 | |
g) | Place of the transaction | London Stock Exchange, AIM | |
Enquiries:
Ergomed plc | Tel: +44 (0) 1483 503205 |
Stephen Stamp (Chief Executive Officer) | |
Numis Securities Limited | Tel: +44 (0) 20 7260 1000 |
Michael Meade / Freddie Barnfield (Nominated Adviser) | |
James Black (Joint Broker) |
Ergomed plc published this content on 01 February 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 01 February 2018 09:49:02 UTC.
Original documenthttp://otp.investis.com/clients/uk/ergomed/rns/regulatory-story.aspx?cid=1407&newsid=973022
Public permalinkhttp://www.publicnow.com/view/1A9E1AA7A7DD988DDC74488514474FDB03A7E2AD
